Lyme disease: Considerations for dentistry

Journal of Orofacial Pain

Volumn 10, Issue 1, 1996, Pages 74-86

  Heir, Gary M ^a,b   Fein, Lesley A ^b  

^a RUTGERS SCHOOL OF DENTAL MEDICINE   (United States)

^b New Jersey Task Force on Lyme Disease ^*  (United States)

Author keywords

Borreliosis; Facial nerve palsy; Lyme disease; Orofacial pain; Spriochetal disease; Temporomandibular

Indexed keywords

ADULT; ANAMNESIS; CASE REPORT; DENTAL CARE; DIFFERENTIAL DIAGNOSIS; FACE PAIN; FACIAL NERVE PARALYSIS; FEMALE; HUMAN; LYME DISEASE; MIDDLE AGED; MYOFASCIAL PAIN; PREVALENCE; REVIEW; UNITED STATES;

ADULT; DENTAL CARE FOR CHRONICALLY ILL; DIAGNOSIS, DIFFERENTIAL; FACIAL PAIN; FACIAL PARALYSIS; FEMALE; HUMANS; LYME DISEASE; MEDICAL HISTORY TAKING; MIDDLE AGED; PREVALENCE; TEMPOROMANDIBULAR JOINT DYSFUNCTION SYNDROME; UNITED STATES;

EID: 0030339596     PISSN: 10646655     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Lukasik S, Wojtowicz A, Betkowski A. Oddzialu Otolaryngologicznego Szpitala Wojewodzkiego Nr 1, Rzeszowie. Wiad Lek 1993;46:506-510.
2. Steere AC, Malawista SE, Snydman DH, Shope RE, Andiman WA, Ross MR, Steele FM. Lyme arthritis: An epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum 1977;20:7-17.
3. Orloski K, Bailey R, Campbell G, Dennis D, Herrington J. National Surveillance for Lyme Disease - USA [pamphlet]. Fort Collins, CO: Centers for Disease Control and Prevention, National Center for Infectious Diseases, Division of Vector-Borne Infectious Diseases, 1995.
4. Craft JE, Schoen RT. Lyme Disease. Croton, CT: Pfizer Central Research, 1993.
5. Clinical Briefs. Am Fam Physician 1993;48:155.
6. Diagnosis and treatment of Lyme disease, National Institute State of the Art Conference. In: Clinical Courier [newsletter of the National Institute of Arthritis and Musculoskeletal and Skin Diseases and National Institute of Allergy and Infectious Disease]. 1991;9(5).
7. Taylor GC. Lyme disease: An overview of its public health significance. J Environ Health 1991;54:24-27.
8. Thacker SB, Keewhan C, Brachman PS. The surveillance of infectious diseases. JAMA 1983;249(9):1181-1185.
9. Brandes J. Lyme disease in Hunterdon increases 322%. Star-Ledger 1993 Nov 4:50.
10. Centers for Disease Control and Prevention (CDC). Information Service, Atlanta, 1994.
11. Smith-Fiola, Porcellini. Am Nurseryman 1991.
12. Cited in: Prevent Tick Bites: Prevent Lyme Disease. Rutgers Cooperative Extension of Ocean County, 1992.
13. Masters EJ, Donnel H, Fobbs M. Missouri Lyme Disease: 1989-1992. J Spirochetal Tick-Borne Disease Dis 1994;1(1).
14. Steere AC. Lyme disease - 1993. Bull Rheum Dis 1993; 42(6):4-7.
15. Steere AC. Lyme disease. Proc Natl Acad Sci USA 1994; 91(7):2378-2383.
16. Barbour AG, Fish D. The biological and social phenomenon of Lyme disease. Science 1993;260(5114):1610-1616.
17. Burrascano JJ Jr. Managing Lyme Disease: Diagnostic Hints and Treatment Guidelines for Lyme Borreliosis, ed 10. East Hamptom, NY, 1995.
18. Schutzer SE, Schwartz RA. Diagnosing Lyme disease: Often simple, often difficult. Cutis 1991;47:229-232.
19. Steere AC. Lyme disease. N Engl J Med 1989;321: 586-596.
20. Land D, DeSilva DM. Coping With Lyme Disease. New York: Henry Holt, 1993.
21. Steere AC. Lyme disease: A growing threat to urban populations. Proc Natl Acad Sci USA 1994;91:2378-2383.
22. Goldfarb D, Sataloff RT. Lyme disease: A review for the otolaryngologist. Ear Nose Throat J 1994;73:824-829.
23. Negussie Y, Remick DG, DeForge LE, Kunkel SL, Eynon A, Griffin GE. Detection of plasma tumor necrosis factor, interleukins 6, and 8 during the Jarisch-Herxheimer Reaction of relapsing fever. J Exp Med 1992;175:1207-1212.
24. Hurley JC. Antibiotic-induced release of endotoxin: A reappraisal. Clin Infect Dis 1992;15:840-854.
25. Georgilis K, Peacocke M, Klempner MS. Fibroblasts protect the Lyme disease spirochete, Borrelia burgdorferi, from ceftriaxone in vitro. J Infect Dis 1992;166:440-444.
26. Klempner MS, Noring R, Roger RA. Invasion of human skin fibroblasts by the Lyme disease spirochete, Borrelia burgdorferi. J Infect Dis 1993;167:1074-1081.
27. Behar S, Porcelli SA. Mechanisms of autoimmune disease induction. Arthritis Rheum 1995;38:458-476.
28. Steere AC, Dwyer E, Winchester RJ. Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles. N Engl J Med 1990;323:219-223.
29. Duray PH. Histopathology of human borreliosis. In: Coyle PK (ed). Lyme Disease. Chicago: Mosby Yearbook, 1992:49-58.
30. Kelsey JH. Lyme disease: An important consideration in the differential diagnosis of TMD. J Mich Dent Assoc 1990;72:209-210.
31. Fallon BA, Nields J. Lyme disease: A neuropsychiatric illness. Am J Psychiatry 1994;151:1571-1583.
32. Eppes SC, Klein JD, Caputo GM, Rose CD. Physician beliefs, attitudes, and approaches toward Lyme disease in an endemic area. Clin Pediatr (Phila) 1994;33:130-134.
33. Lesniak OM, Lirman AV, Antiufev VF. Heart disorders in Lyme disease. Klin Med (Mosk) 1994;72:45-47.
34. Joksimovic Z, Saranovic-Kuljic M, Lazarevic-Milanovic N, Jankovic-Nikolic A, Pavlovic-Nikolic S. Lyme carditis - Case report. Glas Srp Akad Nauka [Med] 1993;43:237-239.
35. Woolf PK. A 12 year old with fever and rash. Pediatr Care 1994;10:249-250.
36. Steere AC, Batsford P, Weinberg M, Alexander J, Berger HJ, Wolfson S, Malawista SE. Lyme carditis: Cardinal abnormalities of Lyme disease. Ann Intern Med 1980; 93:8-16.
37. Fung BP, McHugh GL, Leong JM, Steere AC. Humoral immune response to outer surface protein C of Borrelia burgdorferi in Lyme disease: Role of the immunoglobulin M response in the serodiagnosis of early infection. Infect Immunol 1994;62:3213-3221.
38. Satz N. Immunology and diagnostic test results in Lyme borreliosis. Schweiz Med Wochenschr 1992;122:1779-1791.
39. Dressier F, Whalen JA, Reinhardt BN, Steere AC. Western blotting in the serodiagnosis of Lyme disease. J Infect Dis 1993;167:392-400.
40. Golightly MG. Laborite for the Diagnosis of Lyme Disease. Stony Brook, NY: Stony Brook University Hospital, Dec 1994.
41. Costello CM, Steere AC, Pinkerton RE, Feder HM. A prospective study of tick bites in an endemic area for Lyme disease. J Infec Dis 1989;159:136-139.
42. Rationale for antibiotic prophylaxis upon tick bite. Lyme Disease Foundation Newsletter. Hartford, CT: Lyme Disease Foundation, 1994.
43. Massoraotti EM, Luger SW. Treatment of early Lyme disease. Am J Med 1992;92:396-403.
44. Rahn DW, Malawista SE. Lyme disease: Recommendations for diagnosis and treatment. Ann Intern Med 1991;114:472-481.
45. Wolf SR, Heininger U, Schneider W, Wenzel D. Current aspects in diagnosis and therapy of pediatric facial paralysis. HNO 1994;42:624-628.
46. Fish D. Environmental risk and prevention of Lyme disease. Am J Med 1995;24:98:2S-8S.
47. Rutz DA. Recommendations for Control of Ticks in New York State. Milbrook, NY: Cornell Cooperative Extension, Farm and Home Center [newsletter]. July 1990.
48. Chang YF, Appel MJ, Jacobson RH, Shin SJ, Harpending P, Straubinger R, et al. Recombinant OspA protects dogs against infection and disease caused by Borrelia burgdorferi. Infect Immun 1995;63:3543-3549.
49. Telford SR III, Kantor FS, Lobet Y, Barthold SW, Spielman A, Flavell RA, Fikrig E. Efficacy of human Lyme disease vaccine formulations in a mouse model. J Infect Dis 1995;171:1368-1370.
50. Fikrig E, Telford SR III, Wallich R, Chen M, Lobet Y, Matuschka FR, et al. Vaccination against Lyme disease caused by diverse Borrelia burgdorferi. J Exp Med 1995; 181:215-221.
51. Marconi RT, Konkel ME, Garon CF. Variability of osp genes and gene products among species of Lyme disease spirochetes. Infect Immun 1993;61:2611-2617.
52. Wilske B, Preac-Mursic V, Jauris S, Hofmann A, Pradel I, Soutschek E, et al. Immunological and molecular polymorphisms of OspC, an immunodominant major outer surface protein of Borrelia burgdorferi. Infect Immun 1993;61:2182-2191.
53. Barbour AG. Biological and social determinants of the Lyme disease problem. Infect Agents Dis 1992;1:50-61.